ALEMTUZUMAB
alemtuzumab 12 mg/1.2 mL injection, 1.2 mL vial
ALEMTUZUMAB (10232M)
10232M
Manner of administration:Injection
Restriction 6847
Indication: Multiple sclerosis
Treatment phase: Continuing treatment
Quantities & Cost
| Max qty packs | Max qty units | # of repeats | DPMQ | Max safety net | General Patient Charge |
|---|---|---|---|---|---|
| Max qty packs: 3 | Max qty units: 3 | # of repeats: 0 | DPMQ: $30,849.27 | Max safety net: $25.00 | General Patient Charge: $25.00 |
| Available brands | |||||
| Lemtrada | |||||